Literature DB >> 16690460

Reference range for serum parathyroid hormone.

John F Aloia1, Martin Feuerman, James K Yeh.   

Abstract

OBJECTIVE: To determine whether the reference range for parathyroid hormone (PTH) should be lowered (from 65 pg/mL to a proposed value of 46 pg/mL) with use of the Allegro radioimmunometric assay.
METHODS: We examined the reference range for PTH, adjusted for serum 25-hydroxyvitamin D (25-OHD), in 503 healthy African American and white women, who were 20 to 80 years old. We also analyzed other factors that are thought to influence PTH levels.
RESULTS: Univariate predictors of PTH were identified, and a multivariate model was developed with use of the variables and PTH. Serum PTH was significantly higher in black study subjects than in white study subjects (P<0.02). Increasing PTH was also significantly correlated with increasing body mass index, age, and serum creatinine and with decreasing dietary calcium intake and serum 25-OHD levels. A stepwise multiple linear regression analysis yielded the following predictors of PTH: body mass index (R2=9.4%), age (R2=1.0%), and serum 25-OHD (R2=0.8%). In our study population, many PTH values were above the proposed new upper limit of 46 pg/mL.
CONCLUSION: The upper limit of the reference range for serum PTH should not be changed. Factors to be considered in analysis of serum PTH values in the upper reference range in patients with normocalcemia include obesity, race, 25-OHD levels, advanced age, serum creatinine, and dietary calcium intake.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16690460      PMCID: PMC1482827          DOI: 10.4158/EP.12.2.137

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  41 in total

1.  Vitamin D insufficiency among free-living healthy young adults.

Authors:  Vin Tangpricha; Elizabeth N Pearce; Tai C Chen; Michael F Holick
Journal:  Am J Med       Date:  2002-06-01       Impact factor: 4.965

2.  Technical and clinical characterization of the Bio-PTH (1-84) immunochemiluminometric assay and comparison with a second-generation assay for parathyroid hormone.

Authors:  Masaaki Inaba; Kiyoshi Nakatsuka; Yasuo Imanishi; Masakazu Watanabe; Yuji Mamiya; Eiji Ishimura; Yoshiki Nishizawa
Journal:  Clin Chem       Date:  2003-12-18       Impact factor: 8.327

3.  Risk for osteoporosis in black women.

Authors:  J F Aloia; A Vaswani; J K Yeh; E Flaster
Journal:  Calcif Tissue Int       Date:  1996-12       Impact factor: 4.333

4.  Evaluation of a new, rapid and automated immunochemiluminometric assay for the measurement of serum intact parathyroid hormone.

Authors:  V P Michelangeli; P Heyma; P G Colman; P R Ebeling
Journal:  Ann Clin Biochem       Date:  1997-01       Impact factor: 2.057

5.  Effects of plasma calcium concentration on the relative proportion of hormone and carboxyl fragments in parathyroid venous blood.

Authors:  G P Mayer; J A Keaton; J G Hurst; J F Habener
Journal:  Endocrinology       Date:  1979-06       Impact factor: 4.736

6.  Metabolism of radioiodinated bovine parathyroid hormone in the rat.

Authors:  B V Segre; P D'Amour; J T Potts
Journal:  Endocrinology       Date:  1976-12       Impact factor: 4.736

7.  Decreased bioavailability of vitamin D in obesity.

Authors:  J Wortsman; L Y Matsuoka; T C Chen; Z Lu; M F Holick
Journal:  Am J Clin Nutr       Date:  2000-09       Impact factor: 7.045

8.  Circulating intact parathyroid hormone measured by a two-site immunochemiluminometric assay.

Authors:  R C Brown; J P Aston; I Weeks; J S Woodhead
Journal:  J Clin Endocrinol Metab       Date:  1987-09       Impact factor: 5.958

9.  Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia.

Authors:  S R Nussbaum; R J Zahradnik; J R Lavigne; G L Brennan; K Nozawa-Ung; L Y Kim; H T Keutmann; C A Wang; J T Potts; G V Segre
Journal:  Clin Chem       Date:  1987-08       Impact factor: 8.327

10.  Evidence for alteration of the vitamin D-endocrine system in obese subjects.

Authors:  N H Bell; S Epstein; A Greene; J Shary; M J Oexmann; S Shaw
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

View more
  28 in total

1.  Research methodology: endocrinologic measurements in exercise science and sports medicine.

Authors:  Anthony C Hackney; Atko Viru
Journal:  J Athl Train       Date:  2008 Oct-Dec       Impact factor: 2.860

2.  Timing of onset of CKD-related metabolic complications.

Authors:  Olivier Moranne; Marc Froissart; Jerome Rossert; Cedric Gauci; Jean-Jacques Boffa; Jean Philippe Haymann; Mona Ben M'rad; Christian Jacquot; Pascal Houillier; Benedicte Stengel; Bruno Fouqueray
Journal:  J Am Soc Nephrol       Date:  2008-11-12       Impact factor: 10.121

Review 3.  How the reference values for serum parathyroid hormone concentration are (or should be) established?

Authors:  J-C Souberbielle; F Brazier; M-L Piketty; C Cormier; S Minisola; E Cavalier
Journal:  J Endocrinol Invest       Date:  2016-10-01       Impact factor: 4.256

4.  Use of Calcium and Parathyroid Hormone Nomogram to Distinguish Between Atypical Primary Hyperparathyroidism and Normal Patients.

Authors:  Olga A Lavryk; Allan E Siperstein
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

5.  The 25(OH)D/PTH threshold in black women.

Authors:  John F Aloia; Ding-Geng Chen; Henian Chen
Journal:  J Clin Endocrinol Metab       Date:  2010-08-04       Impact factor: 5.958

6.  Can the combination of calcium and parathormone levels above K/DOQI guidelines be used as a marker of adynamic bone disease in African Americans?

Authors:  Charles J Diskin; Thomas J Stokes; Linda M Dansby; Lautrec Radcliff; Thomas B Carter
Journal:  Int Urol Nephrol       Date:  2010-06-12       Impact factor: 2.370

7.  Micro-CT in the Assessment of Pediatric Renal Osteodystrophy by Bone Histomorphometry.

Authors:  Renata C Pereira; David S Bischoff; Dean Yamaguchi; Isidro B Salusky; Katherine Wesseling-Perry
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-28       Impact factor: 8.237

8.  Defining vitamin D status by secondary hyperparathyroidism in the U.S. population.

Authors:  A A Ginde; P Wolfe; C A Camargo; R S Schwartz
Journal:  J Endocrinol Invest       Date:  2011-05-23       Impact factor: 4.256

9.  Computational analysis of candidate disease genes and variants for salt-sensitive hypertension in indigenous Southern Africans.

Authors:  Nicki Tiffin; Ayton Meintjes; Rajkumar Ramesar; Vladimir B Bajic; Brian Rayner
Journal:  PLoS One       Date:  2010-09-27       Impact factor: 3.240

10.  A cross-sectional association between bone mineral density and parathyroid hormone and other biomarkers in community-dwelling young adults: the CARDIA study.

Authors:  Akira Fujiyoshi; Lynda E Polgreen; Daniel L Hurley; Myron D Gross; Stephen Sidney; David R Jacobs
Journal:  J Clin Endocrinol Metab       Date:  2013-08-21       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.